Some studies have shown that PPARα deficiency in the liver impairs the ability of the organ to utilize fatty acids, resulting in lipid deposition (Montagner et al., 2016), whereas PPARα activation enhances the expression of genes related to fatty acid oxidation and reduces steatosis (Zhu et al., 2017). The gene discussed is PPARA; the disease is steatosis.